**Structural and Functional Characterization of a Minimal Glucagon Antagonist with Extended In Vivo Activity**
The identification of a minimal, high-potency glucagon antagonist capable of sustained in vivo action represents a significant advancement in the development of therapeutics for acute hyperglycemic emergencies. This study focuses…